Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/16731
DC FieldValueLanguage
dc.contributor.authorMarkovikj Temelkova, Snezhanaen_US
dc.contributor.authorFoteva, Martaen_US
dc.contributor.authorStojovska Jovanovska, Elizabetaen_US
dc.contributor.authorStefanovska, Dushicaen_US
dc.contributor.authorBajraktarova Prosheva, Tatjanaen_US
dc.contributor.authorAhmeti, Irfanen_US
dc.date.accessioned2022-02-25T13:19:56Z-
dc.date.available2022-02-25T13:19:56Z-
dc.date.issued2020-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/16731-
dc.publisherSHMSHM - AAMDen_US
dc.relation.ispartofMedicusen_US
dc.titleResults from post-marketing observational study for the assessment of safety of intravenous ibandronic acid in postmenopausal womanen_US
dc.typeArticleen_US
dc.identifier.volume25-
dc.identifier.issue3-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

58
checked on May 5, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.